2012
DOI: 10.1016/j.vetpar.2012.07.011
|View full text |Cite
|
Sign up to set email alerts
|

Dexamethasone treatment interferes with the pharmacokinetics of ivermectin in young cattle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 39 publications
0
7
0
1
Order By: Relevance
“…due to inaccurate estimation of BW) and/or altered drug pharmacokinetics and pharmacodynamics in different animals (e.g. due to nutrition-related variations in fat reserves that may affect the persistent efficacy of ML, erratic absorption of drugs from the site of injection and/or interactions with other co-administered drugs) (González Canga et al., 2008, El-Abdellati et al., 2010, Areskog et al., 2012, Areskog et al., 2014, De Graef et al., 2013). These factors can impair the correct estimation of drug efficacy and detection of AR, particularly in the dose-limiting species C. oncophora .…”
Section: Discussionmentioning
confidence: 99%
“…due to inaccurate estimation of BW) and/or altered drug pharmacokinetics and pharmacodynamics in different animals (e.g. due to nutrition-related variations in fat reserves that may affect the persistent efficacy of ML, erratic absorption of drugs from the site of injection and/or interactions with other co-administered drugs) (González Canga et al., 2008, El-Abdellati et al., 2010, Areskog et al., 2012, Areskog et al., 2014, De Graef et al., 2013). These factors can impair the correct estimation of drug efficacy and detection of AR, particularly in the dose-limiting species C. oncophora .…”
Section: Discussionmentioning
confidence: 99%
“…The pharmacokinetic properties of avermectins may to some extent explain why C. oncophora has a higher resilience to the drug than does O. ostertagi . Pharmacokinetic causes of reduced anthelmintic efficacy and how they are affected by body condition are, as yet, little explored in this context, but we have recently shown that simultaneous treatment with dexamethasone interferes with the pharmacokinetics of IVM (Areskog et al, 2012). Such causes of lack of efficacy and their potential involvement in the selection for AR need to be further studied.…”
Section: Discussionmentioning
confidence: 99%
“…It has previously also been shown that factors affecting the pharmacokinetics of IVM clearly affect the efficacy of the drug [44], but the theory of altered pharmacokinetics as a cause of reduced anthelmintic efficacy is still speculative and few investigations have been carried out. Accordingly, further trials under field conditions are needed to test whether the physiological changes FSG undergo during turnout alter the pharamacokinetics of the drug, and how this reduces the efficacy of treatment.…”
Section: Discussionmentioning
confidence: 99%